Danone's Stock Plummets Following Extended Infant Milk Recalls

Extension of Recalls to Multiple European Countries

The French agri-food group confirmed on Wednesday the extension of its infant milk recalls to France, Poland, Austria, Germany, Hungary, Romania, and Switzerland. This decision follows new recommendations from the European Food Safety Authority regarding the cereulide toxin, a substance produced by certain bacteria that can be potentially harmful to infants' health. The geographical scope of this preventive measure raises concerns about its financial and reputational impact on the specialized nutrition division, considered a strategic pillar in the dairy giant's development. Analysts are questioning the potential consequences on market shares and possible logistical costs associated with these massive product withdrawals, which could impact the current quarter's operational margins. This health crisis comes at an already tense time for the company, whose stock performance has been turbulent with a decline of 8.82% over three months.

Technical Weakness in Stock Performance

From a technical standpoint, Danone now shows worrying signs of weakness. The price is significantly below its fifty-day moving average of 74.40 euros, indicating a short-term bearish momentum that is intensifying. The relative strength index, set at 40, confirms this unfavorable trend as it gradually approaches the oversold zone, reflecting a fatigue in buyers and persistent selling pressure. The stock is currently maintaining above the major support level identified at 65.84 euros, a crucial threshold in the upcoming sessions. The high monthly volatility of 11.44% also reflects the nervousness of investors regarding the uncertainties surrounding the group's valuation. As the publication of the annual results looms in two weeks, operators are now awaiting clarifications on the real impact of this new crisis and the outlook for fiscal year 2026.